NCT06907615
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06907615
Title A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Shanghai Henlius Biotech
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
MD Anderson Cancer Hospital NOT_YET_RECRUITING Houston Texas 77030 United States Details
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College RECRUITING Beijing Beijing Municipality 100021 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field